During the past decade, Wuhan fourth hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wuhan fourth hospital" #1 sponsor was "Benova (Tianjin) Innovative medicine Research Co., Ltd." with 1 trials, followed by "Biohaven Pharmaceuticals, Inc." with 1 trials sponsored, "Shanghai Henlius Biotech" with 1 trials sponsored, "Zhejiang Teruisi Pharmaceutical Inc." with 1 trials sponsored and "Zhong Wang" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wuhan fourth hospital" #1 collaborator was "BioShin Limited" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Wuhan fourth hospital" are "Acute Migraine" (1 trials), "Advanced Non-squamous Non-small-cell Lung Cancer" (1 trials), "Age Related Macular Degeneration" (1 trials), "Chinese Medicine" (1 trials) and "Chronic Insomnia" (1 trials). Many other conditions were trialed in "Wuhan fourth hospital" in a lesser frequency.

Most popular intervention types in "Wuhan fourth hospital" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "China-approved Bevacizumab" (1 trials), "Fosfomycin Tromethamine Granules" (1 trials), "HLX04-O，recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection" (1 trials) and "Lucentis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wuhan fourth hospital" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Wuhan fourth hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Wuhan fourth hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wuhan fourth hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".